JEFFREY E GERSHENWALD to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about TOR Serine-Threonine Kinases.
Connection Strength
0.012
-
Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2. Cancer Res. 2008 Jun 01; 68(11):4392-7.
Score: 0.012